Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Building wealth without taking high risks is achievable with the right strategies. Explore options that prioritize safety and growth.
27,007 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Archer Aviation sparked a strong intraday move after revealing Thunder, a hybrid VTOL platform developed with Anduril...
This analysis breaks down the Q4 2025 earnings transcript for quest resource (qrhc), highlighting revenue, margins, a...
KeyBanc boosted its outlook on CrowdStrike, lifting the price target to $700 after signals from the Mythos conference...
Congress cleared a sweeping housing affordability package and sent it toward a final House vote. The plan aims to red...
A major fund manager parked 1.3 million shares in a leading self-storage REIT, signaling confidence in the sector. Ex...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Micron Technology rides the AI memory wave, but a blowout earnings report invites questions. This guide breaks down t...
The crisis now in its third week intensified after a missile strike on the U.S. embassy in Baghdad and a fuel facilit...
NVIDIA faces a supply bottleneck at its chipmaker that could cap near-term revenue even as AI demand remains strong. ...
Ripple's XRP Ledger is moving toward an on-chain lending layer. This article explains how the ledger's 'missing layer...
Moody’s Analytics now sees a near-even chance of a U.S. recession within the next year, as energy shocks and a coolin...